CECLOR Drug Patent Profile
✉ Email this page to a colleague
When do Ceclor patents expire, and what generic alternatives are available?
Ceclor is a drug marketed by Lilly and is included in three NDAs.
The generic ingredient in CECLOR is cefaclor. There are thirteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefaclor profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ceclor
A generic version of CECLOR was approved as cefaclor by TEVA on September 4th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CECLOR?
- What are the global sales for CECLOR?
- What is Average Wholesale Price for CECLOR?
Summary for CECLOR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Patent Applications: | 4,782 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CECLOR at DailyMed |
![CECLOR drug patent expirations Drug patent expirations by year for CECLOR](/p/graph/s/t/CECLOR-patent-expirations.png)
US Patents and Regulatory Information for CECLOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | CECLOR | cefaclor | CAPSULE;ORAL | 050521-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | CECLOR | cefaclor | FOR SUSPENSION;ORAL | 050522-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | CECLOR | cefaclor | CAPSULE;ORAL | 050521-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | CECLOR | cefaclor | FOR SUSPENSION;ORAL | 050522-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | CECLOR CD | cefaclor | TABLET, EXTENDED RELEASE;ORAL | 050673-002 | Jun 28, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |